- Product Details
Keywords
- Osimertinib Mesylate
- 1421373-66-1
- Osimertinib Mesylate 1421373-66-1
Quick Details
- ProName: Osimertinib Mesylate CAS 1421373-66-1
- CasNo: 1421373-66-1
- Molecular Formula: C29H37N7O5S
- Appearance: White powder
- Application: Ibrutinib is a non-receptor Bruton’s t...
- DeliveryTime: 7-8 working days
- PackAge: 25kg/drum
- Port: Shanghai, Shenzhen, Peking
- ProductionCapacity: 5000 Kiloliter/Week
- Purity: 99%
- Storage: Cool Dry Place
- LimitNum: 1 Kilogram
Superiority
1. Our company is a professional production leading factory in China in pharmaceutical area of many years, our products have export.
d to USA, Greece, Spain, UK, Australia and other countries, and we have got very good feedback from our customers, we had establishe
d a long friendly relations.
2. We have many products in stock, so we can delivery quickly at the very day when receive the payment.
3. High quality, best price, first-class service, high successful delivery rate. Shipment by DHL, TNT, FedEx, HKEMS, UPS, etc
4. we have Professional packaging team, can pack the goods as customized.
Details
Details
D-Ribose CAS#50-69-1 EINECS#200-059-4
CAS |
1421373-66-1 |
MF |
|
MW |
595.71298 |
EINECS |
200-064-1 |
Grade Standard |
Medicine Grade, Tech Grade |
Type |
Auxiliaries and Other Medicinal Chemicals |
Appearance |
White Powder |
Storage |
|
Application |
|
Description |
Osimertinib is active against exon 19 deletions, exon 21 mutations, and also the exon 20 T790M mutations. It is preferentially selective for mutated EGFR, and therefore toxicity at therapeutic doses is lower than for first- and second-generation agents. Notably, osimertinib is able to cross the blood-brain barrier, making it active against disease in the CNS. |
Definition |
ChEBI: A methanesulfonate (mesylate) salt prepared from equimolar amounts of osimertinib and methanesulfonic acid. Used for treatment of EGFR T790M mutation positive non-small cell lung cancer. |